Which ASX Stocks (ASX:XJO) Are Estimated to Be Trading Below Fair Value?

Highlights

• Market volatility has increased as higher oil prices and geopolitical tensions reshape sentiment across Australian equities.
• Several ASX-listed companies are estimated to be trading below their assessed fair value based on discounted cash flow models.
• Companies including Lycopodium, Mesoblast and SKS Technologies Group are drawing attention for their projected growth outlooks.

Heightened geopolitical tensions and stronger oil prices have contributed to increased volatility across Australian equities, prompting investors to reassess valuation opportunities across multiple sectors. During periods of market uncertainty, companies trading below their estimated intrinsic value often attract greater attention as market participants evaluate long-term fundamentals against short-term sentiment. Against this backdrop, the ASX 200 continues to provide a broad snapshot of market performance, while ASX Value Stocks remain firmly on investors' watchlists.

Why are undervalued stocks attracting attention?

Periods of market volatility often create valuation gaps between a company's market price and its estimated intrinsic value.

When broader market sentiment weakens because of macroeconomic uncertainty, geopolitical events or sector rotation, some fundamentally strong businesses may trade below analysts' estimated fair values.

Many valuation models, including discounted cash flow analysis, estimate what a business may be worth based on expected future cash generation rather than current market sentiment.

Which companies are estimated to be trading below fair value?

Several Australian-listed companies have recently been identified as trading below estimated fair value based on discounted cash flow assessments.

Among those attracting attention are:

• Xero (ASX:XRO)
• Superloop (ASX:SLC)
• PolyNovo (ASX:PNV)
• NRW Holdings (ASX:NWH)
• Navigator Global Investments (ASX:NGI)
• Light & Wonder (ASX:LNW)
• Kogan.com (ASX:KGN)
• Frontier Digital Ventures (ASX:FDV)
• Electro Optic Systems Holdings (ASX:EOS)
• Betr Entertainment (ASX:BBT)

These companies operate across technology, healthcare, industrials, consumer, defence and financial services, highlighting the broad range of sectors currently attracting valuation interest.

Why is Lycopodium (ASX:LYL) in focus?

Lycopodium continues to attract attention because analysts estimate the engineering and project delivery company is trading below its assessed fair value.

The company provides engineering, procurement and project management services across the mining, infrastructure and industrial sectors.

Forecast revenue and earnings growth continue to support expectations for ongoing business expansion, driven by demand across resource development and infrastructure projects.

What is supporting interest in Mesoblast (ASX:MSB)?

Mesoblast remains one of Australia's closely watched biotechnology companies.

The regenerative medicine developer continues advancing several late-stage product candidates while expanding its international intellectual property portfolio.

Analysts expect strong earnings growth over the coming years as the company progresses commercialisation opportunities and regulatory milestones.

Why is SKS Technologies Group (ASX:SKS) drawing attention?

SKS Technologies Group has continued benefiting from demand across Australia's digital infrastructure and electrical services sectors.

The company delivers electrical, communications and audio-visual solutions for commercial developments, including hyperscale data centres.

Strong projected revenue growth, expanding project activity and improving profitability expectations have contributed to ongoing valuation interest.

How is discounted cash flow analysis used?

Discounted cash flow analysis estimates a company's intrinsic value by forecasting future cash generation and converting those future cash flows into today's value.

The methodology considers factors such as:

• Expected revenue growth.
• Profitability.
• Capital expenditure.
• Long-term business performance.
• Cost of capital.

Because these estimates rely on assumptions about future business conditions, fair value calculations can change as economic conditions evolve.

Why could market volatility create valuation opportunities?

Periods of heightened uncertainty often result in broad market selling rather than company-specific weakness.

As a result, businesses with stable fundamentals may temporarily trade below estimated intrinsic value.

Investors frequently monitor these situations to determine whether market pricing accurately reflects a company's long-term earnings potential.

What should investors monitor next?

Key developments likely to influence valuations include:

• Company earnings updates.
• Revenue growth trends.
• Project execution.
• Regulatory developments.
• Interest-rate expectations.
• Broader economic conditions.
• Commodity prices and market sentiment.

Changes in any of these factors may influence future fair value assessments.

Market volatility has renewed attention on Australian companies that analysts estimate are trading below their assessed fair values.

Businesses such as Lycopodium (ASX:LYL), Mesoblast (ASX:MSB) and SKS Technologies Group (ASX:SKS) continue attracting interest because of projected earnings growth, expanding operations and positive long-term business outlooks.

While discounted cash flow analysis provides one framework for assessing valuation, investors often combine these estimates with broader fundamental research and evolving market conditions when evaluating listed companies.